Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kraepelin Psiquiatria Clinica
With
Eli Lilly and Company
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Major depression (according to DSM-IV criteria)
MADRS scores superior to 21
Subjects meeting the International Headache Society criteria for chronic primary headache (IHSC-2 codes 1.5.1, 1.6.1, 2.3.1, 2.3.2 and 2.4.3) (ICHS, 2003)
You may not be if
Over 50% reduction on MADRS scores during wash-out period
Illicit drug or alcohol dependence
History of multiple allergies or hypersensitivity to duloxetine
History of epilepsy or significant neurological disorder
Significant suicide risk
Pregnancy or lactation
Sexually active female subjects not using an efficient contraceptive method
Significant laboratory abnormalities at baseline
Significant clinical disease
Subjects meeting DSM-IV criteria for somatisation disorder. (300.81) or presenting with delusional pain symptoms.
Clareo Health | An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache
